Kane Biotech Inc (TSE:KNE)
TSXV:KNE
Canadian Market
Holding TSE:KNE?
Track your performance easily

Kane Biotech (KNE) Financial Statements

0 Followers

Kane Biotech Financial Overview

Kane Biotech's market cap is currently ―. The company's EPS TTM is C$-0.034; its P/E ratio is -3.05; Kane Biotech is scheduled to report earnings on November 13, 2024, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total RevenueC$ 620.44KC$ 51.89KC$ -1.90MC$ 717.85KC$ 28.92K
Gross ProfitC$ 360.50KC$ 40.05KC$ -881.35KC$ 315.26KC$ 23.53K
EBITC$ -1.12MC$ -1.18MC$ -637.84KC$ -1.17MC$ -253.49K
EBITDAC$ -1.06MC$ -1.12MC$ -589.54KC$ -1.10MC$ -193.81K
Net Income Common StockholdersC$ 9.18MC$ -1.40MC$ -1.58MC$ -1.38MC$ -872.54K
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsC$ 1.01MC$ 826.70KC$ 749.25KC$ 1.62MC$ 1.15M
Total AssetsC$ 4.07MC$ 5.80MC$ 5.68MC$ 6.01MC$ 5.58M
Total DebtC$ 928.88KC$ 7.84MC$ 9.25MC$ 9.16MC$ 8.03M
Net DebtC$ -81.05KC$ 7.01MC$ 8.50MC$ 7.54MC$ 6.88M
Total LiabilitiesC$ 4.80MC$ 15.33MC$ 14.09MC$ 13.02MC$ 11.83M
Stockholders EquityC$ -721.70KC$ -11.73MC$ -10.56MC$ -9.19MC$ -8.49M
Cash Flow-
Free Cash FlowC$ -2.20MC$ -991.36KC$ -735.69KC$ -748.06KC$ 376.63K
Operating Cash FlowC$ -2.17MC$ -984.19KC$ -789.89KC$ -715.27KC$ 382.38K
Investing Cash FlowC$ 9.04MC$ -10.32KC$ -12.20KC$ -32.79KC$ -58.65K
Financing Cash FlowC$ -7.57MC$ 809.62KC$ 597.84KC$ 1.23MC$ -167.67K
Currency in CAD

Kane Biotech Earnings and Revenue History

Kane Biotech Debt to Assets

Kane Biotech Cash Flow

Kane Biotech Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis